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Human pluripotent stem cells are a powerful tool
for modeling brain development and disease. The
human cortex is composed of two major neuronal
populations: projection neurons and local interneu-
rons. Cortical interneurons comprise a diverse class
of cell types expressing the neurotransmitter GABA.
Dysfunction of cortical interneurons has been impli-
cated in neuropsychiatric diseases, including schizo-
phrenia, autism, and epilepsy. Here, we demonstrate
the highly efficient derivation of human cortical inter-
neurons in an NKX2.1::GFP human embryonic stem
cell reporter line. Manipulating the timing of SHH
activation yields three distinct GFP+ populations
with specific transcriptional profiles, neurotrans-
mitter phenotypes, and migratory behaviors. Further
differentiation in amurine cortical environment yields
parvalbumin- and somatostatin-expressing neurons
that exhibit synaptic inputs and electrophysiological
properties of cortical interneurons. Our study defines
the signals sufficient for modeling human ventral
forebrain development in vitro and lays the founda-
tion for studying cortical interneuron involvement in
human disease pathology.
INTRODUCTION
Human pluripotent stem cells (hPSCs) are a powerful tool for the
study of human development and disease and for applications
in regenerative medicine. The use of hPSCs differentiated
toward CNS lineages has been of particular interest given thelack of effective therapies for many neurodegenerative and
neuropsychiatric disorders and the availability of protocols for
efficiently directing neuronal specification in vitro (Chambers
et al., 2009). Early studies using hPSCs have been primarily
geared toward neurodegenerative disorders, which are known
to affect specific neuron types such as midbrain dopamine
neurons in Parkinson’s disease (PD; Kriks et al., 2011) or motor
neurons in amyotrophic lateral sclerosis (ALS; Dimos et al.,
2008) and spinal muscular atrophy (SMA; Ebert et al., 2009).
More recent studies suggest the possibility of tackling complex
neuronal disorders such as schizophrenia (Brennand et al.,
2011) or autism-related syndromes (Marchetto et al., 2010;
Pasxca et al., 2011). Unlike in PD, ALS, and SMA, the neuron
types critical for modeling schizophrenia or autism are less
well defined, and no attempts have been made to direct
neuron subtype identity in those studies. There has been
considerable progress in establishing protocols for the deriva-
tion of human embryonic stem cell (ESC)-derived cortical
projection neurons (Espuny-Camacho et al., 2013; Shi et al.,
2012). However, inhibitory neurons such as cortical inter-
neurons may be particularly important in schizophrenia or
autism (Insel, 2010; Lewis et al., 2005). We have previously
demonstrated the derivation of cortical interneurons using an
Lhx6::GFP reporter mouse ESC line (Maroof et al., 2010). How-
ever, the efficiency of cortical interneuron generation was low,
and it was uncertain whether those conditions would apply for
generating human cortical interneurons from PSCs. Modeling
the development of human cortical interneurons in vitro is
of particular interest, because their developmental origin is
controversial: studies suggest considerable differences across
mammalian species (Letinic et al., 2002; Yu and Zecevic,
2011). Furthermore, the protracted in vivo development of
several cortical interneuron types (Anderson et al., 1995) repre-
sents an additional challenge for modeling their differentiation
using human cells in vitro.Cell Stem Cell 12, 559–572, May 2, 2013 ª2013 Elsevier Inc. 559
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hESC-Derived Cortical InterneuronsHere, we present a small-molecule-based strategy for the
efficient induction of human cortical interneurons. Exposure to
the tankyrase inhibitor XAV939 enhances forebrain differentia-
tion. Using an NKX2.1::GFP hESC reporter line, we demonstrate
the selective derivation of three distinct ventral forebrain precur-
sor populations by combining XAV939 treatment with the timed
activation of sonic hedgehog (SHH) signaling. Importantly,
results in both hPSCs and human embryos reveal differences
between mouse and human forebrain development, such as
the human-specific, yet transient, FOXA2 expression within the
ventral forebrain. Finally, mature functional properties and
the expression of late cortical interneuron markers, including
parvalbumin (PV) and somatostatin (SST), demonstrate the
feasibility of studying human cortical interneuron differentiation
from hPSCs in vitro despite their protracted development in vivo.
RESULTS
Combined Inhibition of Wnt and Activation of SHH
Signaling Triggers Efficient Induction of NKX2.1+ Neural
Precursors
The first step in modeling cortical interneuron development is
the robust induction of forebrain precursors. Specification of
anterior and forebrain fate is considered a default program
during neural differentiation of hPSCs (Chambers et al., 2009;
Eiraku et al., 2008; Espuny-Camacho et al., 2013; Gaspard
et al., 2008). However, not all cell lines adopt anterior neural fates
at equal efficiencies (Kim et al., 2011; Wu et al., 2007). Patterning
factors secreted within differentiating cultures such as fibroblast
growth factors (FGFs), Wnts, or retinoids can suppress forebrain
induction and trigger the induction of caudal cell fates. We
recently reported that early, high-dose SHH treatment also
suppresses forebrain markers such as FOXG1 via inhibition of
DKK1 induction (Fasano et al., 2010). This is a concern for
deriving cortical interneurons that are thought to require strong
SHH activation at the NKX2.1+ progenitor stage (Xu et al.,
2010). Here, we tested whether pharmacological inhibition of
WNT signaling can improve FOXG1 induction and subsequently
enable the controlled, SHH-mediated ventralization toward
NKX2.1+ forebrain progenitor fates (Figure 1A).
Neural differentiation of hESCs via the dual SMAD-inhibition
protocol (Chambers et al., 2009) using Noggin + SB431542
(NSB) robustly induced FOXG1+/PAX6+ precursors. Replace-
ment of Noggin with the ALK2/ALK3 inhibitor LDN-193189
(LSB) induced PAX6 expression equally well but showed a trend
toward lower percentages of FOXG1+ cells (Figures 1B and 1C).
Adding recombinant DKK1 or the tankyrase inhibitor XAV939
(Huang et al., 2009), inhibitors of canonical Wnt signaling,
enhanced FOXG1 expression in LSB-treated cultures (Figures
1B–1D). Importantly, the effect of XAV939 on FOXG1 induction
was consistent (Figure 1E) across multiple independent hESC
(HES-3 and WA-09) and human induced PSC (iPSC) lines (C72
line, Papapetrou et al., 2009; SeV6, Kriks et al., 2011). Therefore,
the use of three small molecules (XAV939, LSB, and SB431542;
termed XLSB) enables rapid and robust induction of forebrain
fates across human ESCs and iPSC lines.
We next wanted to test our ability to induce ventral fates using
XLSB in the presence of SHH activators (Figure 1A). The tran-
scription factor NKX2.1 is a marker of ventral prosencephalic560 Cell Stem Cell 12, 559–572, May 2, 2013 ª2013 Elsevier Inc.progenitor populations (Sussel et al., 1999; Xu et al., 2004). Using
a previously established NKX2.1::GFP knockin reporter hESC
line (Goulburn et al., 2011), we observed GFP induction by day
10 following activation of the SHH pathway by recombinant
SHH (R&D Systems, C-25II) and the smoothened activator
purmorphamine (Figure 1F). We found maximal induction of
NKX2.1::GFP at day 18 upon treatment with 1 mM purmorph-
amine and 5nM SHH (Figure 1G), a condition referred to as
‘‘SHH’’ for the remainder of the manuscript. Our past studies
on the derivation of hESC-derived floor plate cells demonstrated
that early treatment with SHH (day 1 of differentiation) is critical
for the efficient induction of FOXA2 (Fasano et al., 2010). In
contrast, we observed here that cells exposed to SHH at late
differentiation stages (day 10 of the XLSB protocol) remain
competent for inducing NKX2.1::GFP as measured by fluores-
cence-activated cell sorting (FACS) (Figure 1H). Therefore,
XLSB+SHH treatment represents a strategy for generating
NKX2.1+ progenitors at high efficiencies.
Timing of SHH Exposure Induces Distinct Ventral
Progenitor Populations
The efficient induction of NKX2.1 largely independent of the
timing of SHH exposure raised the question of whether timing im-
pacts the subtype of NKX2.1+ neural progenitors generated.
Analogous to rodents, NKX2.1 is expressed during early neural
human development in both the FOXG1+ telencephalon and the
FOXG1-negative ventral diencephalon (Figure 2A; Kerwin et al.,
2010; Rakic and Zecevic, 2003). During embryonic
mouse development, NKX2.1 expression in the telencephalon
(FOXG1+) is restricted to the ventral (subcortical) domain. In
contrast, reports in human fetal tissue suggested that NKX2.1
may not be restricted to the ventral forebrain, instead extending
into the dorsal forebrain and cortical anlage (Rakic and Zecevic,
2003;YuandZecevic, 2011).However, thosestudieswere largely
based on the analysis of second-trimester human fetuses, mak-
ing it difficult to distinguish whether NKX2.1+ cells were induced
in the dorsal forebrain or migrated dorsally after induction in the
ventral domain (Fertuzinhos et al., 2009). By performing immuno-
cytochemical analyses in early-stage human embryos (Carnegie
stage 15 [CS15], 38 days post conception), we observed
restriction of NKX2.1 expression to the ventral forebrain (Figures
2B–2E) comparable to the developing mouse CNS. The NKX2.1
domain in the human embryonic ventral forebrain was further
subdivided into an OLIG2+ ganglionic eminence and an OLIG2-
negative preoptic-area anlage (Figures 2C and 2D).
To address whether in vitro timing of SHH exposure affects the
regional identity of the resulting hPSC-derived NKX2.1::GFP+
cells, we compared the identities of sorted cells at day 18 of
differentiation (Figure 2F). In agreement with our previous results
on floor-plate induction (Fasano et al., 2010), we observed that
early SHH exposure (days 2–18) suppressed FOXG1 induction
(Figure 2G, left panel) despite robust induction of NKX2.1::GFP
(see Figure 1H). In contrast, both day 6–18 and day 10–18
treatment groups showed expression of FOXG1 but differed
in OLIG2 expression (Figure 2G, middle and right panels).
We hypothesize that differential expression of FOXG1 and
OLIG2 reflect the distinct NKX2.1+ precursor domains observed
during early human development (Figures 2A–2E) and mimic the
Olig2+ domains during mouse forebrain development (Flames
Figure 1. Wnt Inhibition and Activation of SHH Signaling Yields Highly Efficient Derivation of Forebrain Fates and NKX2.1 Induction
(A) Schematic of the differentiation protocol in the dual-SMAD inhibition paradigm for generating anterior neural progenitors.
(B–E) When either DKK1 or XAV939, both Wnt-signaling antagonists, was added to the dual-SMAD inhibition protocol (DLSB or XLSB), there was a significant
increase in the percentage of FOXG1+ cells (B) without a loss of PAX6 expression (C): **p < 0.01; ***p < 0.001; n.s., not significant; using ANOVA followed by
Scheffe test. (D) Representative immunofluorescent image for FOXG1 (red) and PAX6 (green) expression at day 10 following XLSB treatment. Single-channel
fluorescent images of the marked region are shown in the three right panels. (E) Robust telencephalic specification using XLSBwas also observed at comparable
efficiencies in hiPSCs (lines SeV6 and C72; n = 4).
(F–H) Addition of SHH signaling to the XLSB protocol significantly enhanced the production of NKX2.1::GFP-expressing progenitors. (F) Added from day 4, 5 nM
SHH (C24II) and 1 mm purmorphamine showed synergistic effects in inducing NKX2.1::GFP expression at day 10 (***p < 0.001, compared to SHH). A range
of concentrations of SHH and purmorphamine are compared at day 18 in (G), and again, cotreatment was greatly superior to quite high concentrations of
either SHH or purmorphamine alone (***p < 0.001, compared to no SHH, using ANOVA followed by Scheffe test). (H) Delaying the timing of SHH exposure
between 2 and 10 days of differentiation did not dramatically affect the efficiency of NKX2.1::GFP induction measured at day 18 (***p < 0.001 compared to 0–18,
using ANOVA followed by Scheffe test). P, purmorphamine; S, sonic hedgehog.
Data are from hESC line HES-3 (NKX2.1::GFP) in (B), (C), and (F)–(H); from hESC line WA-09/H9 in (D); and from hESC line WA-09/H9 and hiPSC lines SeV6
and C72 in (E). The scale bar in (D) represents 125 mm. Data in (B), (C), and (E)–(H) are represented as the mean ± SEM.
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hESC-Derived Cortical Interneuronset al., 2007). More than 90% of the NKX2.1::GFP+ cells in the 6–
18 and 10–18 protocols coexpressed FOXG1, and nearly 80% of
the GFP+ cells in the 10–18 protocol coexpressed OLIG2
(Figure 2H).
The impact of the timing of SHH exposure on the derivation of
specific ventral precursor populations was further examined by
global transcriptome analysis (Figures 2I–2K; Table S1 availableonline; all raw data are available in theGene ExpressionOmnibus
[GEO], http://www.ncbi.nlm.nih.gov/geo/). A direct comparison
of day 10–18 versus untreated cultures (no SHH) confirmed
the robust induction of ventral specification markers such as
NKX2.1, NKX2.2, ASCL1, SIX6, OLIG2, and NKX6.2, which
were induced at the expense of dorsal forebrain markers such
as EMX2 and PAX6 (Figure 2I). There were no significantCell Stem Cell 12, 559–572, May 2, 2013 ª2013 Elsevier Inc. 561
Figure 2. Timing of SHH Exposure Determines the Regional Identity of NKX2.1::GFP-Expressing Progenitors
(A) Model of human prosencephalon (sagittal view at CS14) with expression of forebrain patterning markers based on published data (Kerwin et al., 2010). Dien.,
diencephalon; Tien., telencephalon.
(B–E) Coronal (oblique) hemisection of the human prosencephalon at CS15 demonstrates expression of NKX2.1, OLIG2, and PAX6. NKX2.1 and OLIG2 are
expressed in various regions throughout the ventral prosencephalon, whereas PAX6 is restricted to the dorsal prosencephalon and the eye. CTX, cortex; POA,
preoptic area; HYPO, hypothalamus. The scale bar in (B) represents 200 mm. The expression of these proteins is nonoverlapping, except in the ganglionic
eminence (GE) (C), where OLIG2 and NKX2.1 are coexpressed.
(legend continued on next page)
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hESC-Derived Cortical Interneuronsdifferences in the expression of general anterior markers such as
FOXG1 and OTX2 (Figure 2I), supporting the notion that both
populations are of a forebrain identity. Comparison of day 10–
18 and day 2–18 treated cultures (Figure 2J) illustrated differ-
ences in the expression of anterior markers such as FOXG1
versus diencephalic markers such as RAX. In contrast, day 10–
18 versus day 6–18 treated cultures showed less pronounced
differences in forebrain marker expression (Figure 2K). Overall,
our data demonstrate that the window of SHH treatment signifi-
cantly impacts the identity of hPSC-derived NKX2.1 precursors.
One surprising finding from the gene-expression data was the
induction of FOXA2 in all SHH-treated cultures (Figure 2I).
Expression of FOXA2, a marker thought to be largely restricted
to the floor plate within the developing CNS, was confirmed at
day 18 of differentiation in NKX2.1::GFP+ cells of all three SHH
treatment paradigms (Figures S1AandS1B). To addresswhether
FOXA2 expression represents an in vitro artifact following strong
extrinsic activation of SHH signaling or whether FOXA2 expres-
sion occurs in the telencephalon during in vivo development,
we performed histological analyses in the developing mouse
and human forebrain. In mouse embryos (embryonic day 11.5
[E11.5]), FOXA2 expression within the mouse prosencephalon
was segregated from the FOXG1 and NKX2.1 domains (Fig-
ure S1C). However, immunohistochemical analysis for FOXA2
in primary human forebrain tissue (CS15 embryo) confirmed
expression in the telencephalic NKX2.1+ ganglionic eminence
(Figures S1D–S1F). These in vivo data are in agreement with
the in vitro hPSC differentiation data demonstrating (transient)
FOXA2 expression during human ventral forebrain development.
Neuronal Differentiation and Migratory Properties of
hESC-Derived NKX2.1+ Precursors
Cortical interneurons are important for balancing excitation and
inhibition within cortical circuitry and play critical roles in control-
ling developmental plasticity. Cortical interneuron dysfunction
has been implicated in various pathological conditions such as
epilepsy, autism, and schizophrenia (Baraban et al., 2009; Insel,
2010; Lewis et al., 2005; Pen˜agarikano et al., 2011). Our data
demonstrate that day 10–18 treated cells express cortical inter-
neuron progenitor markers such asOLIG2,MASH1, andNKX6.2.
At day 18 of differentiation, NKX2.1+ cells exhibit progenitor cell
properties based on Nestin and Ki67 expression. Prolonged cul-
ture in the absence of extrinsic SHH activation led to a gradual
decrease in Ki67 expression (Figures 3A–3C, upper panels)
and increased percentages of cells expressing the neuronal pre-
cursor markers DCX and TUJ1 (Figures 3A–3C, lower panels). In
addition, many GFP+ cells in the 10–18 and 2–18 conditions ex-
press g-aminobutyric acid (GABA) and subsequently calbindin(F) Schematic illustration of the distinct time periods of SHH and purmorphamin
preoptic area; HYPO, hypothalamus.
(G andH) Immunofluorescence for OLIG2 and FOXG1 in theNKX2.1::GFP line at d
significantly increases the percentage of NKX2.1::GFP+ cells that coexpressed
with SHH after day 10 (10–18 group) enhanced the derivation of NKX2.1::GFP+
compared to 2–18 using ANOVA followed by Scheffe test). Expression of FOX
eminence (Tekki-Kessaris et al., 2001).
(I–K) Microarray data from cells sorted for NKX2.1::GFP expression at day 18 of d
protocol versus no SHH (I), the day 10–18 versus the day 2–18 protocol (J), and the
higher levels in the SHH 10–18 protocol; blue bars indicate genes expressed at l
See also Figure S1 and Table S1.(Figures 3A–3C, lower panels), a marker of tangentially migrating
cortical interneuron precursors (Anderson et al., 1997). Impor-
tantly, western blot analysis at day 32 showed that LHX6 protein,
a marker of postmitotic, migratory cortical interneuron precur-
sors in the mouse, was selectively enriched in the 10–18 condi-
tion. In contrast, the hypothalamic marker RAX was selectively
enriched in the 2–18 condition (Figure 3D). Additional immunocy-
tochemical data showed expression of DLX2 and ASCL1 in most
neuronal progeny derived from the day 10–18 NKX2.1::GFP+
progenitors (Figures 3E–3G). These data indicate that following
withdrawal of extrinsic SHH activators, NKX2.1::GFP+ progeni-
tors give rise to region-specific postmitotic neurons including
immature cortical interneurons.
We next asked whether hESC-derived putative cortical inter-
neuron precursors (day 10–18 group) exhibit the characteristic
migratory potential observed for primary cortical interneurons
in the mouse (Anderson et al., 1997) and human (Letinic et al.,
2002) brain. In both species, major subclasses of cortical inter-
neurons undergo tangential migration on their way from the
ventral telencephalon into the cortex (Anderson et al., 1997; Fer-
tuzinhos et al., 2009; Letinic et al., 2002). NKX2.1::GFP+ cells at
day 32 of differentiation were collected via FACS and injected
into forebrain slices isolated from E13.5 mouse embryos. The
cell injection was carefully targeted to the medial ganglionic
eminence under microscopic visual guidance (Figure 3H). The
migratory potential of NKX2.1::GFP+ cells and their ability to
reach the cortex (see zone 2 in Figure 3H) were assessed for
each treatment group (2–18, 6–18, and 10–18 of SHH treatment;
Figures 3I–3L). At day 2 (Figure 3M), and more pronounced at
day 6 after injection (Figure 3N), GFP+ cells were observed
migrating from the injection site toward the cortex (zone 2).
Remarkably, human cells from the 10–18 treatment, but not
the two other treatment groups, showed a robust propensity
formigration into the neocortical portions of themurine slice (Fig-
ures 3I–3N). These data suggest that day 10–18 treated cells
exhibit migratory properties previously described for interneuron
precursors derived from the primary mouse medial ganglionic
eminence (MGE) (Sussel et al., 1999; Wichterle et al., 1999).
To further probe the migratory capacity of the day 2–18
versus 10–18 treated cells, we transplanted FACS-isolated
NKX2.1::GFP+ cells into the neonatal neocortex of genetically
immunocompromised mice. Four weeks after transplantation
we observed extensive migration in both the radial and tangen-
tial planes within the mouse cortex, but only for the day 10–18
group (Figures 3O and 3P). Similar results were obtained upon
transplantation into the adult cortex (Figure S2), though overall
migration of NKX2.1::GFP+ cells by day 30 in vivo was less
extensive compared to the neonatal grafts.e treatment used in combination with the XLSB protocol. CTX, cortex; POA,
ay 18 of differentiation. Treatmentwith SHH after day 6 (6–18 and 10–18 groups)
FOXG1, as quantified in (H). The scale bar in (G) represents 50 mm. Treatment
cells coexpressing OLIG2 (data are the mean ± SEM; *p < 0.05, ***p < 0.001,
G1, NKX2.1, and OLIG2 indicates a pattern characteristic of the ganglionic
ifferentiation, comparing gene-expression levels between the SHH day 10–18
day 10–18 versus day 6–18 protocol (K). Red bars indicate genes expressed at
ower levels in the day 10–18 protocol. All changes are significant at p < 0.001.
Cell Stem Cell 12, 559–572, May 2, 2013 ª2013 Elsevier Inc. 563
Figure 3. Conversion of Cycling Neural Progenitors to Neuronal Precursors and Assessment of Their Migratory Potential
(A–C) At day 18, cells from the three indicated protocols were subjected to FACS forNKX2.1::GFP expression, then replated and evaluated for colabeling with the
markers indicated. For all three protocols there was a decline in colabeling with markers of progenitors (upper panels: red line, nestin; blue line, Ki67) and an
increase in markers of neuronal differentiation (lower panels: green, GABA; yellow, TUJ1; purple, doublecortin [DCX]; pink, calbindin). Data are the mean ± SEM.
(D) Western blotting showed an increase in the hypothalamic-enriched protein RAX in the 2 to 18 condition and an increase in the MGE-enriched protein LHX6 in
the 10 to 18 condition. Cells were sorted for NKX2.1::GFP prior to analysis.
(E–G) At day 32, many of the NKX2.1::GFP+ cells from the 10 to 18 condition also expressed DLX2 and ASCL1.
(H–N) Grafting of day 32-sortedNKX2.1::GFP+ cells into theMGE of E13.5 coronal mouse slice cultures. (H) Schematic of coronal hemisection demonstrating the
site of transplantation and the zones for quantification of migration. (I and J) In both the 2 to 18 and the 6 to 18 conditions, very few cells migrated into zone 1, and
fewer into zone 2. (K and L) Only the 10 to 18 condition demonstrated significant and robust migration into the cortical and striatal regions, with many GFP+ cells
exhibiting bipolar morphologies consistent with a migratory cell (L). The regions where GFP+ cells were detected were quantified 2 (M) and 6 (N) days post
transplantation (DPT). Data are the mean ± SEM; *p < 0.05, **p < 0.01 using ANOVA followed by Scheffe test.
(O and P) Transplantation of day 32-sorted NKX2.1::GFP+ cells (day 10 to 18 protocol) into the neocortex of neonatal mice followed by their evaluation in fixed
sections at postnatal day 30. In marked contrast to the MGE-like cells from the SHH 10–18 protocol (P), neither the SHH 2–18 protocol (O) nor the SHH 6–18
protocol (data not shown) resulted in extensive migration from the graft site. The scale bar in (P) represents 200 mm.
See also Figures S2 and S3.
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in vivo, we assessed morphological appearance and the expres-
sion of interneuron-related markers in the grafted cells from the564 Cell Stem Cell 12, 559–572, May 2, 2013 ª2013 Elsevier Inc.day 10–18 group (Figure S3). At 1–2 months after grafting into
the neonatal cortex most human cells retained undifferentiated
bipolar or unipolar morphologies and NKX2.1 expression.
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precursor marker DCX, including those with multipolar morphol-
ogies (Figure S3). As in rodents, the large majority of human
interneuron precursors expressed GABA (46/51 GFP+ cells
located at the section surface; Figure S3). In contrast, there
was no colabeling for PV or SST, two proteins marking the
major subclasses of Nkx2.1-lineage interneurons. These data
suggest that even by 6 or 8 weeks posttransplant, the
Nkx2.1::GFP+ cells had not yet differentiated into mature inter-
neurons (Figure S3).
One explanation for the apparent lack of differentiation of
the grafted GFP+ cells in the mouse host cortex could be that
NKX2.1 is downregulated following maturation, as occurs in
mouse cortical interneurons (Marin et al., 2000), resulting in the
loss of GFP expression. For testing this possibility, sections
were examined for expression of SC121, a human-specific pan-
neuronal marker (Kelly et al., 2004). As expected, all GFP+ cells
also expressed SC121 (Figure S3). At 6 weeks after transplan-
tation, less than 10% of human cells were single positive for
SC121 and lacked GFP expression (25 out of 372 SC121+ cells).
In sum, perhaps due to the protracted rate of cortical inter-
neuron maturation in vivo, transplantation studies did not result
in mature cortical interneurons within the first 2 months of
transplant.
Phenotypic and Synaptic Maturation
of NKX2.1+ Neurons In Vitro
We have previously studied cortical interneuron development
using a coculture system in which mouse embryonic MGE-
derived progenitors are plated over a ‘‘feeder culture’’ com-
posed mainly of mouse cortical pyramidal neurons and glia (Xu
et al., 2004). To determine whether aspects of human inter-
neuron maturation would be accelerated in this system relative
to the xenografts, NKX2.1::GFP+ cells were collected via FACS
at day 32 and replated onto cultures of dissociated embryonic
mouse cortex (Figure 4A). The cortical cells were isolated
from E13.5 mouse embryos, a stage prior to the immigration of
the ventrally derived interneurons into the dorsal neocortex
(Anderson et al., 1997). Thus, this coculture system mimics
aspects of normal development with human NKX2.1+ cells
developing in the presence of the glutamatergic cortical pyrami-
dal neurons. Studies were performed in parallel using GFP+ cells
derived from each of the three SHH treatment regimens (Figures
4B–4E). Roughly 80% of the GFP+ cells from the 10–18 treated
‘‘MGE-like’’ cultures, versus 40% from the 2–18 ‘‘hypothalam-
ic-like’’ culture and 15% from the 6–18 culture, expressed
GABA. Likewise, the 6–18 culture that is enriched for telence-
phalic (FOXG1+) cells but lacks expression of the interneuron
precursor marker LHX6 (Figure 3D) was enriched for choline
acetyltransferase (ChAT) neurons.
We next determined whether GFP+ cells from day 10–18
treated cultures (enriched for GABA neurons) undergo
GABAergic synaptic transmission. Whole-cell patch-clamp
electrophysiological studies (Figures 4F–4K) of identified GFP+
cells showed spontaneous firing in both day 10–18 and day 6–
18 treated cultures (Figures 4H and 4I). However, only the day
10–18 group showed modulation of the firing rate of NKX2.1::
GFP+ cells in response to the GABA type A (GABA-A) receptor
antagonist bicuculline (Figure 4J). Because the cortical feederscontained very few murine interneurons (in both day 10–18
and day 6–18 coculture conditions), these results indicate that
hPSC-derived GABAergic neurons mediate the inhibitory synap-
tic output. Accordingly, in the day 6–18 cultures in which
GABAergic neurons are more rare (Figure 4C), the firing rates
following bicuculline exposure remained unchanged (Figure 4K).
To further analyze synaptic inputs onto the NKX2.1::GFP+
cells from the day 10–18 protocol, we examined spontaneous
postsynaptic currents and localization of inhibitory or excitatory
synaptic markers. GFP+ cells cultured on the mouse cortical
feeder for 30 days expressed high levels of vesicular GABA
transporter (VGAT), present within the presynaptic terminal
of GABAergic synapses. The subcellular localization of VGAT
within GFP+ cells closely matched expression of the GABAergic
postsynaptic marker gephyrin (Figures 5A–5E). Whole-cell
patch-clamp analyses demonstrated that NKX2.1::GFP+ cells
receive spontaneous inhibitory postsynaptic currents (sIPSCs;
Figure 5F), which are reversibly blocked by the addition of the
GABA-A receptor antagonist bicuculline. In addition, NKX2.1::
GFP+ cells also receive excitatory inputs, as demonstrated
by the presence of vesicular glutamate transporter 1 (VGLUT1)
expression adjacent to GFP+ putative dendrites and colabeling
with the postsynaptic excitatory synapse marker PSD-95
(Figure 5G–5K). Consistent with the presence of glutamatergic
synaptic inputs, spontaneous excitatory postsynaptic currents
(sEPSCs; Figure 5L) were also readily detected in the NKX2.1::
GFP+ neurons. Additional analysis of spontaneous synaptic
activity in NKX2.1::GFP+ cells is presented in Figure S4 and
Table S2.
Cortical interneurons include a diverse set of neuron types
with distinct roles in cortical development and function (Ba-
tista-Brito and Fishell, 2009). The relatively rapid pace of matura-
tion in our mouse cortical feeder system allowed us to assess
coexpression of more mature interneuron markers and to
define neurotransmitter phenotypes beyond GABA and ChAT.
In the day 2–18 group we observed a large percentage of
GFP+ cells expressing tyrosine hydroxylase (TH) (Figure 6A),
consistent with the dopaminergic nature of NKX2.1-lineage
hypothalamic neurons (Yee et al., 2009). Immunohistochemistry
showed high percentages of neuronal nitric oxide synthase
(nNOS) cells in GFP+ cells from the day 2–18 and Calbindin in
those from the day 10–18 group (Figures 6B and 6C). We also
observed expression of markers characteristic of differentiated
cortical interneurons, including SST and PV (Figures 6D and
6E), again mainly in the day 10–18 group. Representative
images for each subgroup marker, coexpressed together with
NKX2.1::GFP, are presented in Figures 6F–6J. No vasoactive
intestinal polypeptide (VIP)- or calretinin-expressing neurons
were observed, suggesting a lack of cells exhibiting features of
the caudal ganglionic eminence (Xu et al., 2004). The derivation
of NKX2.1+/PV+ neurons was particularly remarkable given the
late developmental expression of this marker in cortical inter-
neurons in vivo (Zecevic et al., 2011). Only a subset of the cells
counted as GFP+/PV+ by the automated image analyses
(Operetta high-content scanner, see Experimental Procedures)
showed high levels of PV expression and exhibited inter-
neuron-like morphologies (about 5% of total GFP+ cells, Fig-
ure 6J). Our results point to the need for further optimization
of the derivation of selective cortical interneuron subtypes.Cell Stem Cell 12, 559–572, May 2, 2013 ª2013 Elsevier Inc. 565
Figure 4. Maturation of NKX2.1+ Cells into Physiologically Active Neurons
(A) Preparation of cortical excitatory neuron cultures from E13.5 mice, onto which human NKX2.1::GFP+ cells (after FACS at day 32) are plated. The coculture
system was critical for promoting neuronal maturation given the protracted in vivo maturation rates of NKX2.1+ cells.
(B–E) After 30 DIV, cultures from the SHH 10–18 conditions were enriched for NKX2.1::GFP+ cells that coexpress GABA (B), quantified in (C) (mean ± SEM;
*p < 0.05, **p < 0.01 using ANOVA followed by Scheffe test). In contrast, only the SHH 6–18 condition was enriched for NKX2.1::GFP colabeling with ChAT (D),
quantified in (E) (mean ± SEM; *p < 0.05 using ANOVA followed by Scheffe test).
(F and G) Spiking patterns of SHH day 10–18 (F) and SHH day 6–18 (G) neurons recorded at 28 DIV. Action potentials were initiated by protocols shown at
the bottom.
(H–K) Spontaneous spiking was recorded from cultures enriched for GABAergic (SHH day 10 to 18) and cholinergic (6 to 18) neurons in the absence (H and I) and
the presence (J and K) of the GABA-A receptor antagonist bicuculline. Bicuculline had little effect on the spontaneous firing activity in the 6 to 18 condition,
consistent with the lack of GABAergic cells from either the mouse feeder or the human NKX2.1::GFP+ cells generated by this protocol.
The scale bars in (B) and (D) represent 50 mm.
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generated at all suggests that the mouse cortical coculture
strategy facilitates expression of cortical interneuron subtype
markers.
Given the protracted maturation of Nkx2.1::GFP+, putative
interneuron precursors in vivo, we were surprised to obtain
morphological, marker-based, and physiological evidence of
interneuron-like differentiation in the coculture system. We next
tested whether similar results can be obtained by growing the566 Cell Stem Cell 12, 559–572, May 2, 2013 ª2013 Elsevier Inc.same Nkx2.1::GFP+ cells on cultures enriched for human
cortical projection neurons. The human cortical feeders were
obtained upon differentiation of hESCs (modified XLSB condi-
tions) followed by FACS for CD44/CD184+/CD24+ neurons
(Yuan et al., 2011) (Figures S5A–S5D). The cortical identity of
the hESC-derived neurons was confirmed by the expression
of VGLUT1, MAP2, CTIP2, and SATB2. Only very few GFAP+
or Nestin+ cells were present under those conditions (Figures
S5E–S5T).
Figure 5. NKX2.1::GFP+ GABAergic Interneurons Receive Both Excitatory and Inhibitory Synaptic Inputs
(A–E) Collapsed z stack confocal image showing NKX2.1::GFP+, the vesicular GABA transporter (VGAT; red in A), and the postsynaptic GABAergic marker
gephyrin (blue in A). The dendrites of this GFP+ cell that colabel with gephyrin are receiving VGAT-expressing presynaptic terminals (arrows). In addition, a GFP+
axonal process formed a VGAT+ presynaptic terminal adjacent to a GFP-negative, gephyrin-expressing postsynaptic process (asterisk).
(F) Whole-cell patch clamp reveals sIPSCs recorded from an NKX2.1::GFP+ neuron (SHH 10 to 18 protocol), which are reversibly blocked by the addition of the
GABA-A receptor antagonist bicuculline.
(G–K) Collapsed z stack confocal image showingNKX2.1::GFP, VGLUT1 (red in G), and the postsynaptic marker PSD-95 (blue in C). This GFP+ cell has dendrites
that colabel with PSD-95 and are adjacent to VGLUT1-expressing presynaptic terminals. Note the presence of a GFP-negative cell expressing VGLUT1 (red in G,
arrowheads), confirming the presence of excitatory glutamatergic neurons in the culture. (L) Consistent with the apparent presence of glutamatergic synaptic
inputs, sEPSCs were detected in theNKX2.1::GFP+ neurons (10 to 18). All cells were plated on mouse cortical feeder following FACS forNKX2.1::GFP at day 32.
See also Figure S4.
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physiological maturation of NKX2.1+ cells plated on mouse
versus human cortical feeders as shown in Table S2. Recordings
were obtained at either 14–16 days in vitro (DIV) or 20–30 DIV
for the mouse feeder condition and 20–30 DIV for the human
cortical feeder condition. Analysis of the basic electrophysio-
logical properties of both the 10– 18 and 6–18 groups plated
on mouse feeders showed more mature characteristics at
later time points of differentiation. There was significant hyper-
polarization of the resting membrane potential (RMP) with time,
as well as a decrease in the input resistance (Ri). In addition,
the action potentials became faster and narrower, as evidenced
by the decrease in the rise time and half-width. In contrast, GFP+
neurons from the day 10–18 condition that were recorded
20–30 days after plating on the human feeder layer retained
relatively immature characteristics, comparable to the mea-surements seen in the younger 14–16 DIV neurons plated onto
a mouse feeder layer. The RMP, action potential rise time, action
potential half-width, and Ri were significantly different in the
cortical feeder condition compared to the 10–18 neurons on
mouse feeders recorded at the same DIV range. Sample traces
depicting qualitative firing properties under the various condi-
tions are shown in Figure S6.
These preliminary findings suggest that the pace of functional
maturation is influenced by the local environment, though the
corresponding mechanisms remain to be determined. Although
it is possible that species-specific maturation rates trigger
the timing of cortical interneuron maturation (e.g., by regulating
activity), it is also possible that there are simply more astrocytes
in mouse versus human feeders (Johnson et al., 2007). Future
studies should include coculture with primary cortical neurons
of human embryonic origin for further corroboration of ourCell Stem Cell 12, 559–572, May 2, 2013 ª2013 Elsevier Inc. 567
Figure 6. Neurochemical Profiling of NKX2.1::GFP+ Cells Grown on Mouse Cortical Feeders for 30 DIV
Cells were labeled by immunofluorescence for the markers indicated, and the results were quantified in graphs (A–E: mean ± SEM; *p < 0.05, **p < 0.01, ***p <
0.001 using ANOVA followed by Scheffe test: (*) p < 0.05 when compared directly to the 6–18 group; the p value did not reach significance in the standard Scheffe
test: p = 0.08). Representative images of cellular labeling are shown in (F–J). In the SHH 2 to 18 condition, most of the cells colabeled with TH (A and F) and nNOS
(B and G). In the 10 to 18 condition, many of the GFP+ cells colabeled with calbindin (Calb; C and H), somatostatin (SST; (D and I), and parvalbumin (PV; E and J),
each of which is present in subpopulations of mature cortical interneurons in humans. All cells were plated on mouse cortical feeder following FACS for
NKX2.1::GFP at day 32. The scale bars in (F)–(J) represent 50 mm. See also Figures S5 and S6 and Table S2.
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that the mouse coculture conditions enhance maturation of
hESC-derived cortical interneurons and enable functional
in vitro studies.
DISCUSSION
The use of WNT-inhibitory molecules such as DKK1 has previ-
ously been proposed for the derivation of telencephalic and optic
progenitors during mouse and human ESC differentiation
(Lamba et al., 2006; Watanabe et al., 2005). We demonstrate
that the tankyrase inhibitor XAV939 (Huang et al., 2009) can
replace recombinant DKK1 for enhancing forebrain induction
using the dual-SMAD inhibition protocol. The use of only three
small molecules (XLSB protocol) renders our induction condi-
tions well defined, cost effective, and robust across multiple
cell lines. XLSB thus represents a general platform for generating
forebrain lineages including cortical interneurons.
A recent paper demonstrated the importance of SHH dosage
during in vitro ventral forebrain specification toward GSX2+,
NKX2.1-negative progenitors capable of generating medium
spiny striatal neurons (Ma et al., 2012). In addition to the SHH
dose, timing can also affect the efficiency of ventral cell-fate
specification (Fasano et al., 2010). A remarkable feature of the
current study is that the difference in timing of SHH activation
is sufficient for triggering the generation of distinct ventral
progenitors of divergent anterior-posterior identity. We have
previously reported the derivation of hESC-derived progenitors
expressing markers of the hypothalamic anlage (Kriks et al.,
2011) following early activation of SHH signaling in the presence568 Cell Stem Cell 12, 559–572, May 2, 2013 ª2013 Elsevier Inc.of FGF8. Our day 2–18 data suggest that addition of FGF8 is not
critical for directing hypothalamic progenitor fate. Cholinergic
neuron derivation from NKX2.1::GFP+ progenitors of the 6–18
group should be of great value for modeling and treating disor-
ders associated with loss of cognitive function. For example, in
Alzheimer’s disease basal forebrain cholinergic neurons are
among the neurons most vulnerable during early stages of the
disease (Whitehouse et al., 1982). However, the main focus of
the current study is the derivation of human cortical interneuron
lineages triggered in the day 10–18 protocol.
Our study points to several surprising differences in human
versus mouse forebrain development, such as human-specific
expression of FOXA2 in hESC-derived ventral forebrain progen-
itors and in CS15 human forebrain tissue. We speculate that
transient FOXA2 expression reflects a prolonged requirement
for SHH signaling during human development given the obvious
differences in brain size and extended proliferation of SHH-
dependent progenitors. To further address this hypothesis, it
will be important to establish a time course of FOXA2 expression
during human ventral forebrain development and to determine
whether FOXA2 is linked to SHH expression as commonly
observed in other FOXA2+ CNS domains such as the floor plate
(Placzek and Briscoe, 2005).
Past studies have reported species differences in cortical
interneuron development, based on the presence of ASCL1+
cells within the second-trimester human fetal cortex (Letinic
et al., 2002). Those data led to the hypothesis that many, and
perhaps most, human cortical interneurons are born within the
cortex itself (Letinic et al., 2002). In contrast, studies in mice
have demonstrated a subcortical origin of most, if not all, cortical
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our study was not specifically geared toward addressing this
issue, we found restricted NKX2.1 expression within the ventral
forebrain in CS15 human embryo and a complete lack of
expression in the dorsal forebrain (see also the Allen Brain Atlas,
http://human.brain-map.org/). Furthermore, the ability of hESC-
derived cortical interneurons to migrate in our slice culture
assay and in the developing murine cortex in vivo suggests
that human cortical interneuron precursors have a capacity for
tangential migration similar to that of their mouse counterparts.
However, a distinctive feature in hESC-derived cortical inter-
neurons was the persistent expression of NKX2.1. Nkx2.1 is
extinguished in mouse cortical interneuron precursors by the
time they leave the MGE prior to entering the cortex (Marin
et al., 2000). Our in vitro data are consistent with findings in the
human neocortex in vivo showing the presence of postmitotic
NKX2.1+ neurons (Fertuzinhos et al., 2009). However, our data
do not rule out the possibility that a subset of our human
ESC-derived cells correspond to striatal interneurons, given
that those share markers of cortical interneurons in the mouse
while retaining NKX2.1 expression (Marin et al., 2000).
Current paradigms of modeling human psychiatric disease
such as schizophrenia feature the use of patient-specific iPSC-
derived neurons (Brennand et al., 2011; Marchetto et al., 2010;
Pasxca et al., 2011). However, those published studies were per-
formed in mixed neural cultures of unclear neuronal subtype
identity and with limited characterization of subtype-specific
synaptic and functional properties. There is a convergence of
postmortem findings that attempt to link genetic defects to psy-
chiatric disorders, such as the interneuron-associated Erbb4
receptor in schizophrenia (Fazzari et al., 2010). Therefore, it is
essential to have access to purified populations of mature
cortical interneurons for modeling human disease. Our results
demonstrate that the highly efficient derivation of cortical
interneurons is possible following timed exposure to develop-
mental cues.
We report that putative hESC-derived GABAergic inter-
neurons receive synaptic inputs fromboth other human interneu-
rons and from excitatory mouse projection neurons. In addition,
cells with neurochemical properties of cortical interneurons
adopt fairly mature physiological properties within 30 days of
coculture. Future studies will be required to address the mecha-
nisms of accelerated in vitro maturation of the NKX2.1::GFP+
neurons on mouse cortical cultures and to determine whether
species-specific timing factors are involved, as suggested
from our preliminary studies using hESC-derived cortical
feeders. However, our data demonstrate that the proposed
culture system can yield synaptically active cortical interneurons
in vitro, a key prerequisite for modeling cortical interneuron
pathologies in psychiatric disorders such as schizophrenia
and autism. The generation of hESC-derived PV-expressing
neurons and the presence of relatively rapid spiking, nonaccom-
modating neurons in these cultures is of particular interest given
the implications of PV interneuron dysfunction in schizophrenia
(Lewis et al., 2005). Fast-spiking PV+ cortical interneurons are
observed late during primate prenatal development and
continue their maturation into early adulthood (Anderson et al.,
1995; Insel, 2010). Given the important role of PV+ neurons
under various pathological conditions our data suggest thatdisease modeling of such states may be feasible using our
differentiation strategies. Another key for the future will be the
development of protocols that allow the enriched generation of
specific cortical interneuron subgroups, such as sSST+ versus
PV+ cells. Our previous results in MGE progenitors indicate
that this decision may yet again be under the control of SHH
signaling, with higher levels promoting SST+ and lower levels
promoting PV+ neurons (Xu et al., 2010).
Finally, future studies will be required to address the full in vivo
potential of human in vitro-derived cortical interneurons for ap-
plications in regenerative medicine. Our current study illustrates
the remarkable migratory potential of the hESC-derived cortical
interneurons upon transplantation into the neonatal mouse
cortex. Transplantation studies into several adult CNS models
of disease will be of particular interest given the potential use
of cortical interneuron grafts in modulating pathological seizure
activity (Baraban et al., 2009), treating aspects of Parkinson’s
disease (Martı´nez-Cerden˜o et al., 2010), and inducing learning
and plasticity within the postnatal brain (Southwell et al., 2010).
One specific challenge for such transplantation studies is the
protracted maturation of grafted hPSC-derived cortical inter-
neuron precursors in vivo. Preliminary longer-term transplanta-
tion studies into the adult mouse cortex confirm their continued
slow maturation rate, with NKX2.1+ putative interneuron pre-
cursors retaining immature growth cones and showing limited
integration at 3 months post grafting (data not shown). Those
data are in contrast to our in vitro coculture work, wherein rapid
functional integration and phenotypic maturation was readily
achieved. In sum, this study provides a framework for the gener-
ation of distinct ventral prosencephalic neuron types that can
be used to study various aspects of development and serves
as a powerful in vitro platform for studying the dysfunction of
specific neuron types implicated in a myriad of neuropsychiatric
diseases.EXPERIMENTAL PROCEDURES
hESC Culture and Neural Differentiation
hESCs (WA-09, HES-3 (NKX2.1::GFP), and iPSCs (C72 and SeV6) were
maintained on mouse embryonic fibroblasts and dissociated with accutase
(Innovative Cell Technologies) for differentiation or dispase for passaging
(Chambers et al., 2009). Differentiation media were described previously
(Kriks et al., 2011): knockout serum replacer (KSR) and N2 medium for neural
induction, and neurobasal medium + B27 (GIBCO) and N2 supplements
(Invitrogen) for neuronal differentiation. Small-molecule compounds were as
follows: XAV939 (2 mM; Stemgent;), LDN193189 (100 nM; Stemgent),
SB431542 (10 mM; Tocris Bioscience), purmorphamine (1–2 mM; Calbiochem),
ascorbic acid (200 mM), and dibutyryl-cyclic AMP (200 mM; both from
Sigma-Aldrich). Recombinant growth factors were as follows: SHH (C25II;
50–500 ng/ml), Noggin (125 ng/ml), DKK1 (250 ng/ml), BDNF (10 ng/ml), all
from R&D Systems, and FGF2 (5–10 ng/ml; Promega).
E13.5 Slice Migration Analysis
Coronal telencephalic slices (250 mm) were prepared as described previously
(Anderson et al., 2001) andmaintained in neurobasal medium/B27 with 5 ng/ml
FGF2 (Promega). hESC-derived NKX2.1::GFP+ cells were isolated by FACS
and carefully injected (5,000 cells) into the periventricular region of the
MGE using an oocyte microinjector (Nanoject II; Drummond Scientific). After
2–6 days, cultures were fixed and immunostained. For cell counting, zone 1
was defined as the region from the ventricular zone of the lateral ganglionic
eminence extending to the pallial-subpallial border, and zone 2 was defined
as the region from the lateral cortex through the neocortex to the cortical hem.Cell Stem Cell 12, 559–572, May 2, 2013 ª2013 Elsevier Inc. 569
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The cortical feeder cultures were prepared by dissociating dorsal cortices
from 250mm coronal slices of E13.5 mouse brain and cultured as described
previously (Xu et al., 2010). For human cortical feeder preparation, cells were
subjected to XLSB-mediated neural induction in the presence of cylcopamine
and purified for CD24+/CD44/CD184+ at day 32 (see Supplemental Experi-
mental Procedures for details).
Gene-Expression Profiling
Total RNA was isolated at day 18 of differentiation from FACS-sorted
NKX2.1::GFP+ cells from three varying differentiation conditions and a
‘‘No SHH’’ condition that did not contain any GFP-expressing cells (Trizol,
Sigma-Aldrich). Samples in triplicate for each group were processed for
Illumina bead arrays (Illumina HT-12) by the Memorial Sloan-Kettering
Cancer Center genomics core facility according to the specifications of the
manufacturer.
Immunocytochemical Analyses
Cultures were fixed in 4% paraformaldehyde and processed for immunocyto-
chemistry. Secondary antibodies were species-specific Alexa-dye conjugates
(Invitrogen). The use of the primary antibodies is summarized in Table S3.
For the automated quantification (Operetta, PerkinElmer), see Supplemental
Experimental Procedures.
Transplantation Studies
Transplantation into the neonatal cortex of NOD-SCID IL2RG/ mice was
conducted as described previously (Wonders et al., 2008). In brief, 50 3
103 cells were injected at following coordinates from bregma (2.0mm A,
2.5mm L, 1.0mm D), targeting cortical layers 3–6. All animal experiments
were carried out in accordance with institutional and National Institutes of
Health guidelines.
Human Tissue Analysis
Tissue derived from aborted human fetuses was obtained from the Depart-
ment of Gynecology, University Bern, Switzerland. The study was approved
by the ethics committee of the Medical Faculty of the University of Bern,
Switzerland, and the ethics committee of the state of Bern, Switzerland
(no. 52/91, 71/94, and 188/95). Written consent was given by the women
seeking abortion.
Statistical Analysis
For all experiments, analysis was derived from at least three independent ex-
periments. Statistical analysis was performed using ANOVA followed by a
Scheffe test to for significance among individual groups (SYSTAT v.13).
FACS
All cells were dissociated using accutase (Stem Cell Technologies) for 30 min,
then resuspended in neurobasal medium/B27 with Y27632 (10 mM; Tocris
Bioscience) and sorted on a BD FACSAria II (gating for side scatter [SSC],
forward scatter [FSC], and DAPI exclusion). For postsort analysis, data was
processed using FlowJo (Tree Star) software.
Electrophysiology
Whole-cell voltage and current clamp recordings were performed as des-
cribed previously (Ying et al., 2007). Details are provided in Supplemental
Experimental Procedures.
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